newsfilter
← Latest News
PR Newswire·

Pulmatrix Announces Year-End and Q4 2023 Financial Results and Provides Corporate Update

Pulmatrix, Inc. ("Pulmatrix" or the "Company") (Nasdaq: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to...